메뉴 건너뛰기




Volumn 57, Issue 5, 2013, Pages 1694-1696

Yttrium 90 radioembolization: The horizon is changing for patients with intermediate and advanced hepatocellular carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; SORAFENIB; YTTRIUM 90;

EID: 84876702614     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26154     Document Type: Article
Times cited : (2)

References (11)
  • 1
    • 84858658381 scopus 로고    scopus 로고
    • EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
    • European Association for the Study of the Liver; European Organization for Research and Treatment of Cancer.
    • European Association for the Study of the Liver; European Organization for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943.
    • (2012) J Hepatol , vol.56 , pp. 908-943
  • 2
    • 79952231921 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma: an update
    • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. HEPATOLOGY 2011; 53: 1020-1022.
    • (2011) HEPATOLOGY , vol.53 , pp. 1020-1022
    • Bruix, J.1    Sherman, M.2
  • 3
    • 84873392306 scopus 로고    scopus 로고
    • Heterogeneity of patients with intermediate (BCLC B) HCC. Proposal for a subclassification to facilitate treatment decisions
    • In press.
    • Bolondi L, Burroughs AK, Dufour JF, Galle P, Mazzaferro V, Piscaglia F, et al. Heterogeneity of patients with intermediate (BCLC B) HCC. Proposal for a subclassification to facilitate treatment decisions. Sem Liver Dis 2012 (In press).
    • (2012) Sem Liver Dis
    • Bolondi, L.1    Burroughs, A.K.2    Dufour, J.F.3    Galle, P.4    Mazzaferro, V.5    Piscaglia, F.6
  • 4
    • 79952039170 scopus 로고    scopus 로고
    • Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization
    • Raoul JL, Sangro B, Forner A, Mazzaferro V, Piscaglia F, Bolondi L, Lencioni R. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 2010; 37: 212-220.
    • (2010) Cancer Treat Rev , vol.37 , pp. 212-220
    • Raoul, J.L.1    Sangro, B.2    Forner, A.3    Mazzaferro, V.4    Piscaglia, F.5    Bolondi, L.6    Lencioni, R.7
  • 5
    • 84869231203 scopus 로고    scopus 로고
    • Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand"
    • Terzi E, Golfieri R, Piscaglia F, Galassi M, Dazzi A, Leoni S, et al. Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand". J Hepatol 2012; 57: 1258-1267.
    • (2012) J Hepatol , vol.57 , pp. 1258-1267
    • Terzi, E.1    Golfieri, R.2    Piscaglia, F.3    Galassi, M.4    Dazzi, A.5    Leoni, S.6
  • 6
    • 80051758429 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version
    • Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, et al. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 2011; 29: 339-364.
    • (2011) Dig Dis , vol.29 , pp. 339-364
    • Kudo, M.1    Izumi, N.2    Kokudo, N.3    Matsui, O.4    Sakamoto, M.5    Nakashima, O.6
  • 7
    • 84984586846 scopus 로고    scopus 로고
    • Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
    • Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010; 4: 439-474.
    • (2010) Hepatol Int , vol.4 , pp. 439-474
    • Omata, M.1    Lesmana, L.A.2    Tateishi, R.3    Chen, P.J.4    Lin, S.M.5    Yoshida, H.6
  • 8
    • 72249087123 scopus 로고    scopus 로고
    • Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes
    • Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology 2010; 138: 52-64.
    • (2010) Gastroenterology , vol.138 , pp. 52-64
    • Salem, R.1    Lewandowski, R.J.2    Mulcahy, M.F.3    Riaz, A.4    Ryu, R.K.5    Ibrahim, S.6
  • 9
    • 80052023374 scopus 로고    scopus 로고
    • Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation
    • Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. HEPATOLOGY 2011; 54: 868-878.
    • (2011) HEPATOLOGY , vol.54 , pp. 868-878
    • Sangro, B.1    Carpanese, L.2    Cianni, R.3    Golfieri, R.4    Gasparini, D.5    Ezziddin, S.6
  • 10
    • 84876743410 scopus 로고    scopus 로고
    • Yttrium(90) radioembolization for intermediate-advanced hepatocarcinoma: a phase II study
    • Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, Morosi C, et al. Yttrium(90) radioembolization for intermediate-advanced hepatocarcinoma: a phase II study. HEPATOLOGY 2013; 57: 1826-1837.
    • (2013) HEPATOLOGY , vol.57 , pp. 1826-1837
    • Mazzaferro, V.1    Sposito, C.2    Bhoori, S.3    Romito, R.4    Chiesa, C.5    Morosi, C.6
  • 11
    • 57749191711 scopus 로고    scopus 로고
    • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
    • Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43.
    • (2009) Lancet Oncol , vol.10 , pp. 35-43
    • Mazzaferro, V.1    Llovet, J.M.2    Miceli, R.3    Bhoori, S.4    Schiavo, M.5    Mariani, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.